Latest Whitepapers

The rapid and accurate identification of microbial contaminants is crucial for quality control in pharmaceutical processes and products. However, until recently, testing labs have relied on time-consuming phenotypic approaches to ensure that safety standards are met.

Novice and expert in vitro diagnostics (IVD) manufacturers agree that developing, optimizing, and launching a lateral flow assay (LFA) test is never routine nor easy.

This whitepaper outlines formulation materials for anode, cathode and electrolyte analysis. It details how to optimize your production needs with customized chemical blends and highlights analytical standard solutions for use in elemental analysis.

This whitepaper highlights the recent developments and performance of three modular benchtop solutions for the high-performance quantitation and kinetics characterization of proteins and their small molecule interactions.

This whitepaper highlights the features and capabilities of a novel system for streamlining affinity analysis for rapid lead molecule screening.

Per-and polyfluoroalkyl substances (PFAS) can persist in our environment for longer than any other artificial substance. They’re associated with negative health effects, yet, they are pervasive in our water systems.

Per-and polyfluoroalkyl substances (PFAS) are highly stable and resistant to degradation. They can persist in our environment for longer than any other artificial substance.

Many factors can risk the reliability of micro- and ultra-microbalances. Their setup surface and leveling as well as changes in environmental conditions, such as temperature, air pressure and relative humidity, can all affect their accuracy and impact results.

Process development teams need detailed information, via a platform that delivers short gradients to allow the required sample throughput to detect HCPs in a low sub-ppm range.

Flow cytometry is an important part of the drug discovery workflow. From screening antibodies to small molecules, combining tests for various analytes in a single panel not only reduces the necessary sample volume but also collects more information in less time, accelerating the drug discovery process.